Diabetes

Disease State Hub

Resources
Research Summaries Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes
Events & Education
Practical Updates in Primary Care

Research Summaries

FDA Alert
fda
FDA Alert
Tirzepatide Gains FDA Approval for Chronic Weight Management
11/13/2023
Tirzepatide is now approved for a new indication. The dual GIP/GLP-1 agonist was previously approved for treating type 2 diabetes in May 2022.
11/13/2023
COVID-19 Roundup
CR
COVID-19 Roundup
Combination Treatment Effective in Managing COVID-19, Incident Diabetes Associated With Infection, and More
06/09/2023
This COVID-19 roundup includes coverage of the combination of amubarvimab and romlusevimab to manage COVID-19 infection, the association between COVID-19 and incident diabetes, and the effectiveness of...
06/09/2023
COVID-19 Roundup
roundup
COVID-19 Roundup
FDA Amends Booster Recommendations for Young Children, Rise in Myocardial Infarction Deaths During Omicron, Vaccination Lowers Risk of Major CV Events, and More
04/19/2023

Jessica Ganga

Jessica Ganga
This COVID-19 roundup includes coverage of the FDA’s amendment to its emergency use authorization of the Pfizer-BioNTech booster for pediatric patients, acute myocardial infection deaths rose during omicron...
04/19/2023
Research Summary
Research Summary
Most Adults With Diabetes Can Use GLP-1 RAs, SGLT-2 Inhibitors But Don't
04/17/2023
Researchers set out to determine the percentage of people in the United States with type 2 diabetes who meet the recommended criteria to use GLP-1 receptor agonists and SGLT-2 inhibitors as well as patients...
04/17/2023
conference coverage
conference coverage
High Opioid Use in Patients With Head, Neck Cancer Undergoing Treatment
04/17/2023

Leigh Precopio

Leigh Precopio
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
04/17/2023
Research Summary
research summary
Research Summary
Bariatric Surgery Reduces Mortality Risk of Specific Conditions
02/10/2023
The researchers examined the mortality risks of bariatric surgery compared with patients who did not undergo surgery using 40-year follow-up.
02/10/2023
Research Summary
Research Summary
New Guidelines for Treatment of CKD, Diabetes Emphasizes Comprehensive Care
02/03/2023
The Work Group from the Kidney Disease: Improving Global Outcomes organization updated its set of guidelines that offers clinical practice guidelines in the treatment of chronic kidney disease and...
02/03/2023
Research Summary
Research Summary
Direct-Acting Antiviral Therapy Lowers Mortality, Cancer Risk in Patients With Hepatitis C
02/01/2023
The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
02/01/2023
Non-Diabetic Kidney Disease
Non-Diabetic Kidney Disease
Non-Diabetic Kidney Disease Prevalent in Individuals With Type 2 Diabetes
01/06/2023
Researchers found a high prevalence of kidney disease in patients with type 2 diabetes mellitus from causes other than diabetes.
01/06/2023
Global Health
Global Health
Type 2 Diabetes Increased in Young Adult Population Globally Over 30 Years
12/29/2022
The researchers aimed to determine the global burden and rise of type 2 diabetes across the globe in adolescents and young adults.
12/29/2022